Gadopentetic acid (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Gadopentetic acid" in English language version.

refsWebsite

Global rank English rank

8nih.gov

4^th place

6doi.org

2^nd place

1canada.ca

1,712^th place

1,063^rd place

1europa.eu

68^th place

117^th place

1patents.google.com

1,182^nd place

725^th place

1semanticscholar.org

11^th place

8^th place

1gov.uk

432^nd place

278^th place

1radiologybusiness.com

low place

canada.ca (Global: 1,712^th place; English: 1,063^rd place)

"Product monograph brand safety updates". Health Canada. 7 July 2016. Retrieved 13 July 2024.

doi.org (Global: 2^nd place; English: 2^nd place)

Murphy KJ, Brunberg JA, Cohan RH (October 1996). "Adverse reactions to gadolinium contrast media: a review of 36 cases". AJR. American Journal of Roentgenology. 167 (4): 847–849. doi:10.2214/ajr.167.4.8819369. PMID 8819369.
Thomsen HS, Morcos SK, Dawson P (November 2006). "Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)?". Clinical Radiology. 61 (11): 905–906. doi:10.1016/j.crad.2006.09.003. PMID 17018301.
Bashir A, Gray ML, Boutin RD, Burstein D (November 1997). "Glycosaminoglycan in articular cartilage: in vivo assessment with delayed Gd(DTPA)(2-)-enhanced MR imaging". Radiology. 205 (2): 551–558. doi:10.1148/radiology.205.2.9356644. PMID 9356644.
Bashir A, Gray ML, Hartke J, Burstein D (May 1999). "Nondestructive imaging of human cartilage glycosaminoglycan concentration by MRI". Magnetic Resonance in Medicine. 41 (5): 857–865. doi:10.1002/(sici)1522-2594(199905)41:5<857::aid-mrm1>3.0.co;2-e. PMID 10332865. S2CID 22939233.
Sherry AD, Caravan P, Lenkinski RE (December 2009). "Primer on gadolinium chemistry". Journal of Magnetic Resonance Imaging. 30 (6): 1240–1248. doi:10.1002/jmri.21966. PMC 2853020. PMID 19938036.
Caravan P, Ellison JJ, McMurry TJ, Lauffer RB (September 1999). "Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications". Chemical Reviews. 99 (9): 2293–2352. doi:10.1021/cr980440x. PMID 11749483.

europa.eu (Global: 68^th place; English: 117^th place)

ema.europa.eu

"List of nationally authorised medicinal products: Gadopentetic acid" (PDF). Europeans Medicines Agency. 14 January 2021.

gov.uk (Global: 432^nd place; English: 278^th place)

"Gadolinium-containing contrast agents: removal of Omniscan and iv Magnevist, restrictions to the use of other linear agents". GOV.UK. 14 December 2017. Retrieved 29 August 2021.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Murphy KJ, Brunberg JA, Cohan RH (October 1996). "Adverse reactions to gadolinium contrast media: a review of 36 cases". AJR. American Journal of Roentgenology. 167 (4): 847–849. doi:10.2214/ajr.167.4.8819369. PMID 8819369.
Thomsen HS, Morcos SK, Dawson P (November 2006). "Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)?". Clinical Radiology. 61 (11): 905–906. doi:10.1016/j.crad.2006.09.003. PMID 17018301.
Bashir A, Gray ML, Boutin RD, Burstein D (November 1997). "Glycosaminoglycan in articular cartilage: in vivo assessment with delayed Gd(DTPA)(2-)-enhanced MR imaging". Radiology. 205 (2): 551–558. doi:10.1148/radiology.205.2.9356644. PMID 9356644.
Bashir A, Gray ML, Hartke J, Burstein D (May 1999). "Nondestructive imaging of human cartilage glycosaminoglycan concentration by MRI". Magnetic Resonance in Medicine. 41 (5): 857–865. doi:10.1002/(sici)1522-2594(199905)41:5<857::aid-mrm1>3.0.co;2-e. PMID 10332865. S2CID 22939233.
Sherry AD, Caravan P, Lenkinski RE (December 2009). "Primer on gadolinium chemistry". Journal of Magnetic Resonance Imaging. 30 (6): 1240–1248. doi:10.1002/jmri.21966. PMC 2853020. PMID 19938036.
Caravan P, Ellison JJ, McMurry TJ, Lauffer RB (September 1999). "Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications". Chemical Reviews. 99 (9): 2293–2352. doi:10.1021/cr980440x. PMID 11749483.

dailymed.nlm.nih.gov

"Magnevist- gadopentetate dimeglumine injection". DailyMed. Retrieved 29 August 2021.

ncbi.nlm.nih.gov

Sherry AD, Caravan P, Lenkinski RE (December 2009). "Primer on gadolinium chemistry". Journal of Magnetic Resonance Imaging. 30 (6): 1240–1248. doi:10.1002/jmri.21966. PMC 2853020. PMID 19938036.

patents.google.com (Global: 1,182^nd place; English: 725^th place)

US 5021236, "Method of enhancing NMR imaging using chelated paramagnetic ions bound to biomolecules"

radiologybusiness.com (Global: low place; English: low place)

"EU pulls gadolinium contrast agents over deposition concerns". www.radiologybusiness.com. Retrieved 18 August 2020.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Bashir A, Gray ML, Hartke J, Burstein D (May 1999). "Nondestructive imaging of human cartilage glycosaminoglycan concentration by MRI". Magnetic Resonance in Medicine. 41 (5): 857–865. doi:10.1002/(sici)1522-2594(199905)41:5<857::aid-mrm1>3.0.co;2-e. PMID 10332865. S2CID 22939233.

Gadopentetic acid (English Wikipedia)

canada.ca (Global: 1,712th place; English: 1,063rd place)

doi.org (Global: 2nd place; English: 2nd place)

europa.eu (Global: 68th place; English: 117th place)